A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

BACKGROUND: Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of the seriou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Surg Case Rep
Autores principales: Urakawa, Shinya, Sakai, Daisuke, Miyazaki, Yasuhiro, Kudo, Toshihiro, Katou, Aya, Inagaki, Chiaki, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Takiguchi, Shuji, Satoh, Taroh, Mori, Masaki, Doki, Yuichiro
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2017
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736507/
https://ncbi.nlm.nih.gov/pubmed/29260338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0399-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares